CRL250117P340000
- 0.00
- 0.000.00%
Charles River Newsroom
Jefferies Adjusts Price Target on Charles River Laboratories International to $169 From $196, Keeps Hold Rating
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $227
BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $210
Citi Maintains Charles River(CRL.US) With Sell Rating, Announces Target Price $175
Charles River Analyst Ratings
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $220
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $220
Cautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target Adjustment
Charles River Labs Is Maintained at Neutral by B of A Securities
Charles River Analyst Ratings
BofA Securities Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $210
Baird Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $197
Charles River Labs Is Maintained at Hold by TD Cowen
Charles River Analyst Ratings
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $227
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Raises Target Price to $227
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $225
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Raises Target Price to $225
J.P. Morgan Sticks to Its Hold Rating for Charles River Labs (CRL)
Hold Rating for Charles River Labs Amid Mixed Performance and Market Uncertainties